Eli Lilly’s 7.5, 12.5 and 15 milligram solutions of Mounjaro are in short supply, and the drugmaker predicts supply levels to normalize by the end of July, the FDA said in a July 25 post. The 10 milligram solution is also on back order, and that shortage is expected to end in September.
The company listed the reason for the shortage as “demand increase.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
